Oxagen

About:

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

Website: http://www.oxagen.co.uk

Top Investors: Bessemer Venture Partners, Invesco, Wellcome Trust, SV Health Investors, Novartis Venture Fund

Description:

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.